Melissa Little is a highly accomplished researcher with extensive expertise in kidney development and regenerative therapies. Serving as the CEO of the Novo Nordisk Foundation Centre for Stem Cell Medicine and Chief Scientist at the Murdoch Children's Research Institute in Melbourne, Australia, she has made substantial contributions to the field of stem cell research. Her pioneering work in generating kidney organoids from human pluripotent stem cells has been widely adopted worldwide for disease modeling, drug screening, and renal replacement therapies. Melissa's exceptional achievements have earned her numerous prestigious awards and memberships in various scientific academies, underscoring her significant impact on nephrology and stem cell research.